Literature DB >> 2178752

Regulatory peptides and the onset of nausea and vomiting.

J Kucharczyk1, R K Harding.   

Abstract

There is no direct evidence that peptide hormones mediate vomiting observed during various cardiovascular, cerebrovascular, visceral, or neurological disorders. On the other hand, recent studies in animal models have demonstrated that several endogenous vasoactive neuropeptides can induce short-latency emesis following systemic or intracranial injections. This article reviews experimental data on peptide-induced emesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2178752     DOI: 10.1139/y90-043

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  5 in total

Review 1.  Neuropharmacology of emesis in relation to clinical response.

Authors:  B Costall; R J Naylor
Journal:  Br J Cancer Suppl       Date:  1992-12

Review 2.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 3.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

4.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

5.  Clinical analysis of post-traumatic vomiting.

Authors:  S Ando; M Otani; K Moritake
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.